Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States

Cancer

Volumn 118, Issue 5, 2012, Pages 1260-1267

  Prasad, Sandip M ^a   Gu, Xiangmei ^b   Lipsitz, Stuart R ^b   Nguyen, Paul L ^b   Hu, Jim C ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

cost; imaging; prostate cancer; staging; utilization

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; ASIAN; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; COHORT ANALYSIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CRYOTHERAPY; EDUCATIONAL STATUS; GROUPS BY AGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HIGH SCHOOL; HISPANIC; HOUSEHOLD INCOME; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICARE; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; PROSTATE CANCER; PROSTATECTOMY; PROTON THERAPY; RACE DIFFERENCE; SOCIAL STATUS; UNITED STATES; UNNECESSARY PROCEDURE; URBAN RURAL DIFFERENCE;

AGE OF ONSET; AGED; AGED, 80 AND OVER; CARCINOMA; DIAGNOSTIC IMAGING; HEALTH CARE COSTS; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROSTATIC NEOPLASMS; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 84863116332     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26416     Document Type: Article

References (30)

1. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60: 277-300.
2. Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 1997; 277: 1445-1451. (Pubitemid 27208886)
3. Galper SL, Chen MH, Catalona WJ, Roehl KA, Richie JP, D'Amico AV,. Evidence to support a continued stage migration and decrease in prostate cancer specific mortality. J Urol. 2006; 175: 907-912. (Pubitemid 43200015)
4. American Urological Association. Prostate-specific antigen (PSA) best practice policy. Oncology (Williston Park). 2000; 14: 267-272.
5. Abuzallouf S, Dayes I, Lukka H,. Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol. 2004; 171: 2122-2127. (Pubitemid 38625418)
6. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG,. Potential for cancer-related health-services research using a linked Medicare-tumor registry database. Med Care. 1993; 31: 732-748.
7. Klabunde CN, Potosky AL, Legler JM, Warren JL,. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000; 53: 1258-1267. (Pubitemid 32007842)
8. Mohler JL,. The 2010 NCCN clinical practice guidelines in oncology on prostate cancer. J Natl Compr Canc Netw. 2010; 8: 145.
9. Board of Trustees, 2007 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. Published April 23, 2007. Available at: Accessed April 17, 2011.
10. Steinbrook R,. Guidance for guidelines. N Engl J Med. 2007; 356: 331-333. (Pubitemid 46148775)
11. Lavery HJ, Brajtbord JS, Levinson AW, Nabizada-Pace F, Pollard ME, Samadi DB,. Unnecessary imaging for the staging of low-risk prostate cancer is common. Urology. 2011; 77: 274-278.
12. Levran Z, Gonzalez JA, Diokno AC, Jafri SZ, Steinert BW,. Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer? Br J Urol. 1995; 75: 778-781.
13. Dinan MA, Curtis LH, Hammill BG, et al. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA. 2010; 303: 1625-1631.
14. Brook RH,. The end of the quality improvement movement: long live improving value. JAMA. 2010; 304: 1831-1832.
15. Asch SM, Kerr EA, Keesey J, et al. Who is at greatest risk for receiving poor-quality health care? N Engl J Med. 2006; 354: 1147-1156.
16. McNeil BJ,. Shattuck lecture. Hidden barriers to improvement in the quality of care. N Engl J Med. 2001; 345: 1612-1620. (Pubitemid 33126842)
17. Shahinian VB, Kuo YF, Gilbert SM,. Reimbursement policy and androgen-deprivation therapy for prostate cancer. N Engl J Med. 2010; 363: 1822-1832.
18. Iglehart JK,. Linking compensation to quality. Medicare payments to physicians. N Engl J Med. 2005; 353: 870-872. (Pubitemid 41247925)
19. Physician Quality Reporting Initiative. Available at: Accessed November 1, 2010.
20. Muntener M, Epstein JI, Hernandez DJ, et al. Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy. Eur Urol. 2008; 53: 767-775.
21. Cohen MS, Hanley RS, Kurteva T, et al. Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis. Eur Urol. 2008; 54: 371-381.
22. Cooperberg MR, Lubeck DP, Grossfeld GD, Mehta SS, Carroll PR,. Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor. J Urol. 2002; 168: 491-495. (Pubitemid 34793279)
23. Nguyen PL, Gu X, Lipsitz SR, et al. Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol. 2011; 29: 1517-1524.
24. Brenner DJ, Hall EJ,. Computed tomography-an increasing source of radiation exposure. N Engl J Med. 2007; 357: 2277-2284. (Pubitemid 350190758)
25. Song Y, Skinner J, Bynum J, Sutherland J, Wennberg JE, Fisher ES,. Regional variations in diagnostic practices. N Engl J Med. 2010; 363: 45-53.
26. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL,. The implications of regional variations in Medicare spending. Part 1: The content, quality, and accessibility of care. Ann Intern Med. 2003; 138: 273-287. (Pubitemid 36205924)
27. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW,. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases-implications for pay for performance. JAMA. 2005; 294: 716-724. (Pubitemid 41159291)
28. Wilson IB, Dukes K, Greenfield S, Kaplan S, Hillman B,. Patients' role in the use of radiology testing for common office practice complaints. Arch Intern Med. 2001; 161: 256-263. (Pubitemid 32102394)
29. Bhargavan M, Sunshine JH,. Utilization of radiology services in the United States: levels and trends in modalities, regions, and populations. Radiology. 2005; 234: 824-832. (Pubitemid 40250826)
30. Studdert DM, Mello MM, Sage WM, et al. Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. JAMA. 2005; 293: 2609-2617. (Pubitemid 40741199)